Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 1/2007

01-06-2007 | Original Article

Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14+R) in high-risk diffuse large cell lymphoma

Authors: Agustin Avilés, MD, María J. Nambo, Natividad Neri, Sergio Cleto, Claudia Castañeda, Judith Huerta-Guzmàn, Edgar Murillo, Margarita Contreras, Alejandra Talavera, Martha González

Published in: Medical Oncology | Issue 1/2007

Login to get access
Metadata
Title
Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14+R) in high-risk diffuse large cell lymphoma
Authors
Agustin Avilés, MD
María J. Nambo
Natividad Neri
Sergio Cleto
Claudia Castañeda
Judith Huerta-Guzmàn
Edgar Murillo
Margarita Contreras
Alejandra Talavera
Martha González
Publication date
01-06-2007
Publisher
Humana Press
Published in
Medical Oncology / Issue 1/2007
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/BF02685907

Other articles of this Issue 1/2007

Medical Oncology 1/2007 Go to the issue

Original Article

Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer

Original Article

A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer

Review

Melanoma inhibition by cyclooxygenase inhibitors

Original Article

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

Original Article

Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment

Original Article

Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits